Human interleukin-2 Recruiting Phase 4 Trials for Pulmonary Tuberculosis (TB) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04766307A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2